AML patients are often treated using allogeneic hematopoietic stem cell transplantation (allo-HCT), where they receive stem cells from a donor. Unfortunately, despite advancements with allo-HCT, many ...

Hany Elmariah, MD, discusses dose-limiting toxicities of fedratinib in a phase 1 study exploring the drug in patients with myeloproliferative neoplasms after HCT.

The UAE continues its significant contributions to space exploration, driven by its qualified national workforce and ...

With a commitment to excellence, HCT is transforming health care training through advanced technology, immersive learning experiences and strategic international partnerships. The HCT, the ...